Boxer Capital Management, LLC — 13F Holdings

2026 Q3  ·  75 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Boxer Capital Management, LLC maintained a portfolio of 75 distinct positions. The most significant new addition was ACHIEVE LIFE SCIENCE INC, now representing 1.51% of the total fund value. They heavily accumulated shares in SURROZEN INC, increasing the position by 23.1%. The fund also reduced its exposure to CAPRICOR THERAPEUTICS INC by 53.9%.
Position History hover any row below to update
Loading…
PCA Score Concentration Risk
Risk ENB
Total Positions
75
Quarter
2026 Q3
Top Holding
TNGX (22.8%)
Top 10 Concentration
71.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 75

Boxer Capital Management, LLC Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
TNGX
TANGO THERAPEUT...
Healthcare 22.82% 25.61% #1
Prev: #1
6.5
—
-350,000 -3.2%
P
S
10,526,219 $262,629,164 2024 Q4 13F Filing 2026-09-30 2026-11-16
KOD
KODIAK SCIENCES...
Healthcare 12.17% 4.34% #2 3
Prev: #5
6.5
—
no change no change
P
S
1,477,600 $140,076,480 2024 Q4 13F Filing 2026-09-30 2026-11-16
RVMD
REVOLUTION MEDI...
Healthcare 8.92% 7.05% #3 1
Prev: #2
5.6
—
no change no change
P
S
500,000 $102,630,000 2024 Q4 13F Filing 2026-09-30 2026-11-16
KYMR
KYMERA THERAPEU...
Healthcare 5.10% 3.71% #4 2
Prev: #6
5.0
—
95,451 22.2%
P
S
524,551 $58,639,556 2024 Q4 13F Filing 2026-09-30 2026-11-16
REPL
REPLIMUNE GROUP...
Healthcare 4.92% 3.32% #5 3
Prev: #8
4.5
—
295,159 7.4%
P
S
4,278,159 $56,642,825 2024 Q4 13F Filing 2026-09-30 2026-11-16
ABVX
ABIVAX SA
Healthcare 4.09% 6.07% #6 3
Prev: #3
1.6
—
-130,029 -21.5%
P
S
474,971 $47,031,628 2025 Q3 13F Filing 2026-09-30 2026-11-16
SRZN
SURROZEN INC
Healthcare 3.81% 2.03% #7 7
Prev: #14
4.0
—
255,000 23.1%
P
S
1,360,683 $43,786,778 2025 Q4 13F Filing 2026-09-30 2026-11-16
CORT
CORCEPT THERAPE...
Healthcare 3.36% 2.20% #8 5
Prev: #13
2.3
—
no change no change
P
S
335,500 $38,659,665 2026 Q1 13F Filing 2026-09-30 2026-11-16
PGEN
PRECIGEN INC
Healthcare 3.21% 2.21% #9 3
Prev: #12
1.8
—
-829,661 -16.1%
P
S
4,320,339 $36,982,101 2025 Q3 13F Filing 2026-09-30 2026-11-16
QURE
UNIQURE NV
Healthcare 2.99% 5.21% #10 6
Prev: #4
1.7
—
-80,057 -5.3%
P
S
1,423,243 $34,385,550 2024 Q4 13F Filing 2026-09-30 2026-11-16
DFTX
DEFINIUM THERAP...
Healthcare 2.26% 3.54% #11 4
Prev: #7
0.9
—
-314,885 -31.5%
P
S
683,615 $26,018,386 2026 Q1 13F Filing 2026-09-30 2026-11-16
AMLX
AMYLYX PHARMACE...
Healthcare 2.26% 1.08% #12 10
Prev: #22
2.9
—
93,153 11.6%
P
S
893,153 $25,990,752 2024 Q4 13F Filing 2026-09-30 2026-11-16
SYRE
SPYRE THERAPEUT...
Healthcare 2.19% 0.67% #13 14
Prev: #27
3.9
—
183,054 183.1%
P
S
283,054 $25,200,297 2024 Q4 13F Filing 2026-09-30 2026-11-16
PTGX
PROTAGONIST THE...
Healthcare 2.08% 1.57% #14 1
Prev: #15
1.8
—
no change no change
P
S
170,000 $23,951,300 2025 Q2 13F Filing 2026-09-30 2026-11-16
CELC
CELCUITY INC
Healthcare 1.98% 3.28% #15 6
Prev: #9
0.8
—
-130,291 -31.3%
P
S
286,239 $22,761,725 2025 Q3 13F Filing 2026-09-30 2026-11-16
IRD
OPUS GENETICS I...
Healthcare 1.91% 0.87% #16 8
Prev: #24
3.8
—
1,718,660 61.1%
P
S
4,533,660 $21,942,914 2026 Q1 13F Filing 2026-09-30 2026-11-16
QTTB
Q32 BIO INC
Healthcare 1.85% 3.02% #17 7
Prev: #10
1.2
—
-571,668 -18.2%
P
S
2,577,642 $21,317,099 2026 Q2 13F Filing 2026-09-30 2026-11-16
URGN
UROGEN PHARMA L...
Healthcare 1.77% 1.39% #18
Prev: #18
1.7
—
no change no change
P
S
500,000 $20,315,000 2025 Q2 13F Filing 2026-09-30 2026-11-16
ACHV
ACHIEVE LIFE SC...
Healthcare 1.51% — #19
Prev: #—
4.1
—
2,150,000 —
NEW
2,150,000 $17,393,500 2026 Q3 13F Filing 2026-09-30 2026-11-16
CCCC
C4 THERAPEUTICS...
Healthcare 1.20% — #20
Prev: #—
4.0
—
4,150,000 —
NEW
4,150,000 $13,819,500 2026 Q3 13F Filing 2026-09-30 2026-11-16
TRAX
FIRST TRACKS BI...
Healthcare 0.74% — #21
Prev: #—
3.8
—
240,000 —
NEW
240,000 $8,505,600 2026 Q3 13F Filing 2026-09-30 2026-11-16
STTK
SHATTUCK LABS I...
Healthcare 0.70% 0.52% #22 12
Prev: #34
2.3
—
175,396 17.5%
P
S
1,175,396 $8,016,200 2026 Q2 13F Filing 2026-09-30 2026-11-16
SABS
SAB BIOTHERAPEU...
Healthcare 0.69% — #23
Prev: #—
3.8
—
2,500,000 —
NEW
2,500,000 $7,925,000 2026 Q3 13F Filing 2026-09-30 2026-11-16
CGEM
CULLINAN THERAP...
Healthcare 0.60% — #24
Prev: #—
3.7
—
450,000 —
NEW
450,000 $6,907,500 2024 Q4 13F Filing 2026-09-30 2026-11-16
CTNM
CONTINEUM THERA...
Healthcare 0.58% 0.61% #25 7
Prev: #32
1.2
—
no change no change
P
S
494,000 $6,629,480 2025 Q4 13F Filing 2026-09-30 2026-11-16
CYTK
CYTOKINETICS IN...
Healthcare 0.57% 0.64% #26 3
Prev: #29
1.2
—
no change no change
P
S
100,000 $6,591,000 2025 Q3 13F Filing 2026-09-30 2026-11-16
PALI
PALISADE BIO IN...
Healthcare 0.56% 0.76% #27 2
Prev: #25
1.2
—
no change no change
P
S
4,799,875 $6,479,831 2025 Q4 13F Filing 2026-09-30 2026-11-16
CAPR
CAPRICOR THERAP...
Healthcare 0.53% 2.53% #28 17
Prev: #11
0.2
—
-752,319 -53.9%
P
S
642,837 $6,087,666 2025 Q4 13F Filing 2026-09-30 2026-11-16
ETRA
ELECTRA THERAPE...
Healthcare 0.44% — #29
Prev: #—
3.7
—
450,000 —
NEW
450,000 $5,062,500 2026 Q3 13F Filing 2026-09-30 2026-11-16
ANTX
AN2 THERAPEUTIC...
Healthcare 0.44% 0.27% #30 16
Prev: #46
2.7
—
195,000 26.0%
P
S
944,035 $5,022,266 2026 Q1 13F Filing 2026-09-30 2026-11-16
MAZE
MAZE THERAPEUTI...
Healthcare 0.41% — #31
Prev: #—
3.7
—
175,465 —
NEW
175,465 $4,769,138 2026 Q3 13F Filing 2026-09-30 2026-11-16
EDSA
EDESA BIOTECH I...
Healthcare 0.34% 0.13% #32 25
Prev: #57
3.1
—
732,363 357.3%
P
S
937,363 $3,946,298 2026 Q2 13F Filing 2026-09-30 2026-11-16
RLAY
RELAY THERAPEUT...
Healthcare 0.31% 0.63% #33 3
Prev: #30
0.1
—
-250,000 -55.6%
P
S
200,000 $3,610,000 2024 Q4 13F Filing 2026-09-30 2026-11-16
KZIA
KAZIA THERAPEUT...
Healthcare 0.31% 0.59% #34 1
Prev: #33
0.1
—
-188,500 -33.7%
P
S
371,500 $3,564,542 2026 Q2 13F Filing 2026-09-30 2026-11-16
N/A
ATTOVIA THERAPE...
Unknown 0.30% — #35
Prev: #—
3.6
—
200,000 —
NEW
200,000 $3,428,000 — 13F Filing 2026-09-30 2026-11-16
PMVP
PMV PHARMACEUTI...
Healthcare 0.30% — #36
Prev: #—
3.6
—
2,050,000 —
NEW
2,050,000 $3,423,500 2026 Q3 13F Filing 2026-09-30 2026-11-16
N/A
CRESCENT BIOPHA...
Unknown 0.29% 0.62% #37 6
Prev: #31
0.1
—
-226,843 -50.0%
P
S
226,843 $3,309,639 — 13F Filing 2026-09-30 2026-11-16
ZNTL
ZENTALIS PHARMA...
Healthcare 0.24% — #38
Prev: #—
3.6
—
1,013,555 —
NEW
1,013,555 $2,807,547 2024 Q4 13F Filing 2026-09-30 2026-11-16
SRPT
SAREPTA THERAPE...
Healthcare 0.24% 0.20% #39 14
Prev: #53
1.1
—
no change no change
P
S
150,000 $2,733,000 2025 Q2 13F Filing 2026-09-30 2026-11-16
ALLO
ALLOGENE THERAP...
Healthcare 0.21% 0.23% #40 9
Prev: #49
1.1
—
no change no change
P
S
1,500,000 $2,400,000 2026 Q1 13F Filing 2026-09-30 2026-11-16
NRIX
NURIX THERAPEUT...
Healthcare 0.21% 0.18% #41 14
Prev: #55
1.1
—
no change no change
P
S
100,000 $2,371,000 2024 Q4 13F Filing 2026-09-30 2026-11-16
SION
SIONNA THERAPEU...
Healthcare 0.18% — #42
Prev: #—
3.6
—
391,723 —
NEW
391,723 $2,060,462 2026 Q3 13F Filing 2026-09-30 2026-11-16
CLNN
CLENE INC
Consumer Defensive 0.17% 0.22% #43 9
Prev: #52
1.1
—
no change no change
P
S
477,515 $1,948,261 2025 Q4 13F Filing 2026-09-30 2026-11-16
ACRS
ACLARIS THERAPE...
Healthcare 0.14% — #44
Prev: #—
3.6
—
300,000 —
NEW
300,000 $1,578,000 2026 Q3 13F Filing 2026-09-30 2026-11-16
MIST
MILESTONE PHARM...
Healthcare 0.05% 0.07% #45 15
Prev: #60
1.0
—
no change no change
P
S
666,666 $577,132 2024 Q4 13F Filing 2026-09-30 2026-11-16
NMRA
NEUMORA THERAPE...
Healthcare 0.05% 0.26% #46 1
Prev: #47
0.0
—
-1,045,948 -52.3%
P
S
954,052 $568,805 2026 Q2 13F Filing 2026-09-30 2026-11-16
KPTI
KARYOPHARM THER...
Healthcare 0.01% 0.22% #47 4
Prev: #51
0.0
—
-175,000 -57.8%
P
S
127,536 $155,593 2025 Q4 13F Filing 2026-09-30 2026-11-16
SRZNW
SURROZEN INC
Unknown 0.00% 0.00%
Sold All 😨
(Was: #63)
0.0
—
-66,666 -100.0%
CLOSED
— $— 2024 Q4 13F Filing 2026-09-30 2026-11-16
RGNX
REGENXBIO INC
Healthcare 0.00% 0.01%
Sold All 😨
(Was: #62)
0.0
—
-15,000 -100.0%
CLOSED
— $— 2026 Q1 13F Filing 2026-09-30 2026-11-16
PEPG
PEPGEN INC
Healthcare 0.00% 0.04%
Sold All 😨
(Was: #61)
0.0
—
-272,892 -100.0%
CLOSED
— $— 2025 Q3 13F Filing 2026-09-30 2026-11-16
Showing 1-50 of 75 holdings

Unlock Full Boxer Capital Management, LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →